Long-term Outcomes Associated With Open vs Endovascular Abdominal Aortic Aneurysm Repair in a Medicare-Matched Database.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
02 05 2022
Historique:
entrez: 13 5 2022
pubmed: 14 5 2022
medline: 18 5 2022
Statut: epublish

Résumé

Endovascular aneurysm repair is associated with a significant reduction in perioperative mortality and morbidity compared with open aneurysm repair in the treatment of abdominal aortic aneurysm. However, this benefit decreases over time owing to increased reinterventions and late aneurysm rupture after endovascular repair. To compare long-term outcomes of endovascular vs open repair of abdominal aortic aneurysm. This multicenter retrospective cohort study used deidentified data with 6-year follow-up from the Medicare-matched Vascular Quality Initiative Vascular Implant Surveillance and Interventional Outcomes Network database. Patients undergoing first-time elective endovascular or open abdominal aortic aneurysm repair from 2003 to 2018 were propensity score matched. Patients with ruptured abdominal aortic aneurysm, concomitant procedures, or prior history of abdominal aortic aneurysm repair, were excluded. Data were analyzed from January 1, 2003, to December 31, 2018. First-time elective endovascular or open repair for abdominal aortic aneurysm. The primary long-term outcome of interest was 6-year all-cause mortality, rupture, and reintervention. Secondary outcomes included 30-day mortality and perioperative complications. Among a total of 32 760 patients (median [IQR] age, 75 [70-80] years; 25 706 [78.5%] men) who underwent surgical abdominal aortic aneurysm repair, 28 281 patients underwent endovascular repair and 4479 patients underwent open repair. After propensity score matching, there were 2852 patients in each group. Open repair was associated with significantly lower 6-year mortality compared with endovascular repair (548 deaths [35.6%] vs 608 deaths [41.2%]; hazard ratio [HR], 0.83; 95% CI, 0.74-0.94; P = .002), with increases in mortality starting from 1 to 2 years (84 deaths [4.3%] vs 126 deaths [6.7%]; HR, 0.63; 95% CI, 0.48-0.83; P = .001) and 2 to 6 years (211 deaths [25.8%] vs 241 deaths [30.6%]; HR, 0.73; 95% CI, 0.61-0.88; P = .001). Open repair, compared with endovascular repair, also was associated with significantly lower rates of 6-year rupture (117 participants [5.8%] vs 149 participants [8.3%]; HR, 0.76; 95% CI, 0.60-0.97; P < .001) and reintervention (190 participants [11.6%] vs 267 participants [16.0%]; HR, 0.67; 95% CI, 0.55-0.80; P < .001). Open repair was associated with significantly higher odds of 30-day mortality (OR, 3.56; 95% CI, 2.41-5.26; P < .001) and complications. These findings suggest that overall mortality after elective abdominal aortic aneurysm repair was higher with endovascular repair than open repair despite reduced 30-day mortality and perioperative morbidity after endovascular repair. Endovascular repair additionally was associated with significantly higher rates of long-term rupture and reintervention. These findings emphasize the importance of careful patient selection and long-term follow-up surveillance for patients who undergo endovascular repair.

Identifiants

pubmed: 35560049
pii: 2792290
doi: 10.1001/jamanetworkopen.2022.12081
pmc: PMC9107027
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2212081

Commentaires et corrections

Type : CommentIn

Références

Int J Cardiol. 2017 Jun 1;236:427-431
pubmed: 28096046
J Vasc Surg. 2019 Feb;69(2):432-439
pubmed: 30686338
J Endovasc Ther. 2014 Jun;21(3):439-47
pubmed: 24915595
J Vasc Surg. 2020 Dec;72(6):2153-2160
pubmed: 32442604
Eur J Vasc Endovasc Surg. 2007 Sep;34(3):253-6
pubmed: 17689818
N Engl J Med. 2004 Oct 14;351(16):1607-18
pubmed: 15483279
J Vasc Surg. 2018 May;67(5):1404-1409.e2
pubmed: 29097041
BMC Med Res Methodol. 2017 Apr 28;17(1):78
pubmed: 28454568
N Engl J Med. 2019 May 30;380(22):2126-2135
pubmed: 31141634
J Vasc Surg. 2019 Dec;70(6):1823-1830
pubmed: 31126766
JAMA Surg. 2015 Oct;150(10):957-63
pubmed: 26154598
Clin Ther. 2007 Jun;29(6 Pt 1):1284-92
pubmed: 18036390
Semin Vasc Surg. 2012 Sep;25(3):131-5
pubmed: 23062491
Eur J Vasc Endovasc Surg. 2020 Mar;59(3):385-397
pubmed: 31899100
J Vasc Surg. 2017 Jun;65(6):1625-1635
pubmed: 28216362
Ann Vasc Surg. 2015 Aug;29(6):1181-7
pubmed: 26004950
JAMA Surg. 2015 Jul;150(7):632-6
pubmed: 25970850
JAMA Surg. 2014 Dec;149(12):1260-5
pubmed: 25337871
Ann Surg. 2017 Nov;266(5):713-719
pubmed: 28742684
Lancet. 2016 Nov 12;388(10058):2366-2374
pubmed: 27743617
J Vasc Surg. 2015 Jul;62(1):27-35
pubmed: 25864044
J Vasc Surg. 2014 Apr;59(4):915-20
pubmed: 24360584
J Vasc Surg. 2019 Sep;70(3):954-969.e30
pubmed: 31147117
J Am Coll Surg. 2016 Apr;222(4):579-89
pubmed: 26905372
Ann Vasc Surg. 2017 Apr;40:74-84
pubmed: 27903469
J Vasc Surg. 2014 Jun;59(6):1512-7
pubmed: 24560865
J Vasc Surg. 2018 Jan;67(1):126-133
pubmed: 28760581
J Vasc Interv Radiol. 2018 Feb;29(2):203-209
pubmed: 29249593
Eur J Vasc Endovasc Surg. 2009 Jan;37(1):15-22
pubmed: 19008129
Br J Surg. 2019 Apr;106(5):523-533
pubmed: 30883709
Ann Vasc Surg. 1991 Nov;5(6):491-9
pubmed: 1837729
J Vasc Surg. 2017 Sep;66(3):751-759.e1
pubmed: 28222989
J Vasc Surg. 2012 May;55(5):1529-37
pubmed: 22542349
Lancet. 2004 Sep 4-10;364(9437):843-8
pubmed: 15351191
J Endovasc Ther. 2015 Oct;22(5):734-44
pubmed: 26286073
N Engl J Med. 2015 Jul 23;373(4):328-38
pubmed: 26200979
J Vasc Surg. 2017 Nov;66(5):1379-1389
pubmed: 29061270
JAMA Surg. 2016 Sep 1;151(9):838-45
pubmed: 27192100
Ann Surg. 2021 Jul 1;274(1):179-185
pubmed: 31290764
JAMA. 2009 Oct 14;302(14):1535-42
pubmed: 19826022

Auteurs

Kevin Yei (K)

University of California, San Diego, La Jolla.

Asma Mathlouthi (A)

University of California, San Diego, La Jolla.

Isaac Naazie (I)

University of California, San Diego, La Jolla.

Nadin Elsayed (N)

University of California, San Diego, La Jolla.

Bryan Clary (B)

University of California, San Diego, La Jolla.

Mahmoud Malas (M)

University of California, San Diego, La Jolla.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH